Xarelto for Prevention of Stroke in Patients With Atrial Fibrillation "XANTUS"

Completed

Phase N/A Results N/A

Main Contacts

Name Phone E-mail
Bayer Study Director Study Director
Bayer Clinical Trials Contact Contact clinical-trials-contact@bayerhealthcare.com

Other Locations

Name City State Country Status
Name Unavailable Many Locations Austria Unknown_status_icon
Name Unavailable Many Locations Belgium Unknown_status_icon
Name Unavailable Many Locations Czech Republic Unknown_status_icon
Name Unavailable Many Locations Denmark Unknown_status_icon
Name Unavailable Many Locations France Unknown_status_icon
Name Unavailable Many Locations Germany Unknown_status_icon
Name Unavailable Many Locations Greece Not_yet_recruiting_status_icon
Name Unavailable Many Locations Hungary Unknown_status_icon
Name Unavailable Many Locations Ireland Unknown_status_icon
Name Unavailable Many Locations Israel Unknown_status_icon
Name Unavailable Many Locations Italy Not_yet_recruiting_status_icon
Name Unavailable Many Locations Moldova, Republic of Unknown_status_icon
Name Unavailable Many Locations Netherlands Unknown_status_icon
Name Unavailable Many Locations Norway Unknown_status_icon
Name Unavailable Many Locations Poland Unknown_status_icon
Name Unavailable Many Locations Portugal Unknown_status_icon
Name Unavailable Many Locations Russian Federation Unknown_status_icon
Name Unavailable Many Locations Slovakia Unknown_status_icon
Name Unavailable Many Locations Slovenia Unknown_status_icon
Name Unavailable Many Locations Spain Withdrawn_status_icon
Name Unavailable Many Locations Sweden Unknown_status_icon
Name Unavailable Many Locations Ukraine Unknown_status_icon
Name Unavailable Many Locations United Kingdom Unknown_status_icon
Name Unavailable Many locations Canada Unknown_status_icon